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Abstract
Background: The COVID-19 pandemic and the UK government’s subsequent coronavirus action plan have fun-
damentally impacted on every aspect of healthcare. One area that is severely affected is ear, nose and throat
(ENT)/laryngology where speech and language therapists (SLTs) engage in a diverse range of practice with pa-
tients with a range of conditions, including voice disorders, airway problems, and head and neck cancers (HNCs).
A large majority of these patients are in high-risk categories, and many specialized clinical practices are vulnerable.
In addition, workforce and research issues are challenged in both the immediate context and the future.
Aims: To discuss the threats and opportunities from the COVID-19 pandemic for SLTs in ENT/laryngology with
specific reference to clinical practice, workforce and research leadership.
Methods & Procedures: The relevant sections of the World Health Organisation’s (WHO) health systems building
blocks framework (2007) were used to structure the study. Expert agreement was determined by an iterative
process of multiple-group discussions, the use of all recent relevant policy documentation, and other literature
and shared documentation/writing. The final paper was verified and agreed by all authors.
Main Contribution: The main threats to ENT/laryngology SLT clinical services include increased patient com-
plexity related to COVID-19 voice and airway problems, delayed HNC diagnosis, reduced access to instrumental
procedures and inequitable care provision. The main clinical opportunities include the potential for new modes
of service delivery and collaborations, and harnessing SLT expertise in non-instrumental assessment. There are
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several workforce issues, including redeployment (and impact on current services), training implications and psy-
chological impact on staff. Workforce opportunities exist for service innovation and potential extended ENT/SLT
practice roles. Research is threatened by a reduction in immediate funding calls and high competition. Current
research is affected by very limited access to participants and the ability to conduct face-to-face and instrumental
assessments. However, research opportunities may result in greater collaboration, and changes in service delivery
necessitate robust investigation and evaluation. A new national set of research priorities is likely to emerge.
Conclusions & Implications: The immediate impact of the pandemic has resulted in major disruption to all aspects
of clinical delivery, workforce and research for ENT/laryngology SLT. It is unclear when any of these areas will
resume operations and whether permanent changes to clinical practice, professional remits and research priorities
will follow. However, significant opportunity exists in the post-COVID era to re-evaluate current practice, embrace
opportunities and evaluate new ways of working.
Keywords: COVID-19, ENT SLT services, ENT SLT workforce, ENT SLT research.
What this paper adds
What is already known on the subject
• ENT/laryngology SLTs manage patients with a range of conditions, including voice disorders, airway
problems and HNCs. The diverse scope of clinical practice involves highly specialized assessment and
treatment practices in patients in high-risk categories. A large majority of active research projects in this
field are patient focused and involve instrumental assessment. The COVID-19 pandemic has created both
opportunities and threats for ENT SLT clinical services, workforce and research.
What this paper adds to existing knowledge
• This study provides a discussion of the threats and opportunities from the COVID-19 pandemic for
ENT/laryngology SLT with specific reference to clinical practice, workforce and research leadership.
What are the potential or actual clinical implications of this work?
• The COVID-19 pandemic has resulted in major disruption to all aspects of clinical delivery, workforce
and research for ENT/laryngology SLT. Changes to clinical practice, professional remits and research pri-
orities are of indeterminant duration at this time, and some components could be permanent. Significant
clinical practice, workforce and research opportunities may exist in the post-COVID era.
Introduction
The UK government’s coronavirus action plan to the
COVID-19 pandemic includes four stages: contain-
ment, delay, research and mitigation. The consequent
legislation (The Health Protection Regulations 2020)
enables action in five main areas: (1) increasing the
available health and social care workforce; (2) easing
the burden on frontline staff and prioritizing care for
people with the most pressing needs; (3) containing
and slowing the virus by reducing unnecessary social
contacts: (4) managing the deceased with respect and
dignity; and (5) supporting people. These measures are
temporary and subject to regular review. However, con-
sequently, the delivery of every aspect of healthcare by
all clinical and non-clinical departments in the National
Health Service (NHS) has been fundamentally affected
(Willan et al. 2020). The Royal College of Speech and
Language Therapists (RCSLT) has stated that, as spe-
cialists in communication and swallowing, speech and
language therapists (SLTs) have a crucial role to play as
part of wider multidisciplinary teams (MDTs) in this
response (RCSLT 2020a). This includes: (1) support-
ing people with communication and swallowing needs
who contract the virus; (2) ensuring relevant informa-
tion is accessible to those who have speech, language
and communication needs; (3) urging relevant retirees
and graduates to increase the available health and social
care workforce; and (4) reducing risk of contracting the
virus to SLTs, their loved ones and those they care for
and work with.
The NIHR CRN ENT SLT (National Institute for
Health Research Clinical Research Network, Ear Nose
and Throat sub-specialty Speech and Language Ther-
apy) Research Group represents a collaboration of expe-
rienced clinical researchers in ENT/laryngology (voice
and airway disorders, and head and neck cancer—
HNC). This group provides a broad geographical rep-
resentation of specialist ENT/laryngology clinical ser-
vices in England and includes all the main researchers
in the field. A large majority of this group are also at the
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forefront of clinician services associated with COVID-
19 NHS service delivery.
ENT SLT services have seen major alterations dur-
ing the pandemic. Direct changes include a steep in-
crease in referrals for COVID-19-related voice, swal-
lowing and airway problems. Indirectly, voice, airways
and HNC patients have experienced less face-to-face
SLT contact, more remote consultations, fewer joint
clinics and less access to instrumental assessments, with
alterations and delays to their proposed treatment. The
aim of this paper is to describe these changes and po-
tential consequences in more detail, and to discuss the
threats and opportunities from the COVID-19 pan-
demic for SLTs in ENT/laryngology practice.
Methodology
This discussion paper represents the consensus view of
the NIHR CRN ENT SLT Research Group (see the
acknowledgements). A series of discussions has been
distilled by the authors and verified by the whole group
before publication. We have used the World Health
Organisation’s (WHO) health systems building-blocks
framework (WHO 2007) to select those relevant to this
discussion, namely: service delivery (clinical consider-
ation), workforce and leadership/governance (research
implications). The expert consensus of the current
context and the future implications and opportunities
are discussed for each of these three areas.
Service delivery/clinical implications
ENT SLTs engage in a diverse scope of clinical practice
with many working within highly specialized MDTs.
These teams serve patients with a range of conditions
including HNCs, benign voice disorders and airway
problems. Many of these patients fall into the ‘vulnera-
ble’ category, in particular those with a laryngectomy or
long-term tracheostomy, who have an increased risk of
pneumonia (El Cheikh et al. 2018).
The pandemic presents new clinical challenges for
the foreseeable future with 95.6% of respondents in
a recent RCSLT survey stating that the pandemic was
having an impact on their professional roles, respon-
sibilities and duties (RCSLT 2020b). Here we sum-
marize the impact of COVID-19 on: (1) existing
ENT SLT services and service delivery, before high-
lighting clinical considerations, adaptations and po-
tentially new clinical opportunities for each of three
main patient groups within this sphere of practice:
(2) HNC services, (3) voice services and (4) airways
services.
General ENT SLT clinical implications
Under usual circumstances professional guidelines ad-
vise that all patients with suspected laryngeal disorders
should undergo endoscopic evaluation of the larynx
(EEL) (RCSLT 2019). Similarly, endoscopic or vide-
ofluoroscopic evaluations of swallowing are key diag-
nostic and therapeutic techniques. These specialized
services have been disrupted by the pandemic with
prioritization of resources, rigorous risk criteria and
new protocols being introduced to limit virus transmis-
sion (RCSLT 2020c, 2020d). This cessation of routine
nasendoscopic procedures impacts patient care with the
potential for misdiagnosis, suboptimum treatment and
unnecessary healthcare utilization (Idrees and FitzGer-
ald 2015).
In the absence of endoscopy ENT SLTs are using
their clinical skills for the benefit of patients. ENT SLTs
can assess and manage patients using detailed and thor-
ough history-taking, perceptual and acoustic evaluation
of voice and comprehensive clinical assessment of swal-
lowing. They are also able to use their work with pa-
tients to prioritize those who do need further instru-
mental evaluation.
Routine, face-to-face SLT outpatient appointments
have been postponed indefinitely to limit unnecessary
footfall in hospitals with 75% of SLTs reporting that
there are patients on their caseload no longer receiving
intervention when they would usually do so (RCSLT
2020b). Many SLT procedures, including dysphagia as-
sessment, have been designated high-risk Aerosol Gen-
erating Procedures (AGPs) in the RCSLT professional
guidelines and evidence review (Bolton et al. 2020).
This means that emergency cases such as urgent laryn-
gectomy voice prosthesis changes require ENT SLTs to
follow rigorous infection control guidance and wear full
personal protective equipment (PPE).
Innovative approaches to continuing and re-
establishing clinical practice are being trialled and im-
plemented. Over 70% of SLTs surveyed have identi-
fied changes made as a result of the pandemic that
are of benefit to their clinical practice, patients and/or
service (RCSLT 2020b). This has included setting up
telehealth services to offer assessment and rehabilita-
tion via telephone and video-conferencing reviews. This
has benefits to patients with previous research show-
ing favourable clinical outcomes and good acceptance
(Burns et al. 2017). The potential for aspects of tele-
health practice to be incorporated within the ENT SLT
pathway beyond the pandemic is already part of the
conversations amongst many teams.
Another challenge with the interruption in outpa-
tient ENT SLTs has been the reduction in MDT clin-
ics. Close liaison with surgical, allied health and nurs-
ing colleagues is crucial to form a clear, well-evidenced
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treatment plan for ENT patients. Limitations to face-
to-face MDT contacts have been overcome using tele-
health and forward planning for services to reopen in
the most efficient, safe and effective way possible for
patients.
For ENT SLTs there are very real concerns that the
current climate means that people are delaying general
practitioner and accident and emergency (A&E) visits
with health concerns (NHS England News 2020). If
patients present with later stage (more advanced) dis-
ease, they will require more intensive treatment, and
by extension, greater SLT rehabilitation needs. Undi-
agnosed laryngeal disorders might worsen over time,
increasing their complexity and hindering treatment
response (Stachler et al. 2018).
ENT SLTs also need to be vigilant of the high
prevalence of laryngeal injury post-extubation in inten-
sive care unit (ICU) settings, which can cause dyspho-
nia and/or dysphagia (Brodsky et al. 2018) Laryngeal
trauma might also arise from acute cough (Slinger et al.
2019), with post-viral symptoms impacting voice and
swallowing even in patients who have not been admit-
ted to hospital. This leads to the potential for a surge
of new referrals for ENT SLTs as the initial peak of the
pandemic passes and needs to be accounted for in ser-
vice delivery.
Head and neck cancer (HNC) services
In the UK NHS, HNC is managed by MDTs work-
ing within cancer centres, with the SLT being a core
MDT member (National Institute for Health and
Clinical Excellence 2004). As such, SLTs are involved
at every stage of an individual’s care from diagnosis
and pre-habilitation throughout oncological treatment,
post-treatment rehabilitation, survivorship and pallia-
tion. The current pandemic has triggered a range of
changes to many aspects of the hitherto relatively well-
established head and neck patient pathway.
New referral pathways
Most suspected cancer referrals are received via the
2-week wait referral pathway (Department of Health
2000) via general practitioners or dentists, or through
A&E departments. This referral rate has significantly
reduced due to public fears in accessing healthcare.
For referrals that are received via a 2-week wait re-
ferral pathway, hospital consultants are using telephone
consultations. Without the benefit of face-to-face clini-
cal examination, alternate innovations that enhance dif-
ferential diagnosis is vital. One such innovation is the
use of a remote evidence-based triage system (Paleri
et al. 2020) to stratify patients according to likely risk of
cancer. Patients with voice and swallowing symptoms,
which are least likely to be attributable to a cancer di-
agnosis, could potentially be directed toward SLT-led
clinics (see voice services below).
MDT meetings and clinics
Weekly MDT meetings are a feature of all cancer cen-
tres in the UK and are the focal point for discussion
and decision-making around each patient’s individual
treatment plan. These meetings are now either severely
reduced or conducted virtually. SLT input around func-
tional outcome in relation to different treatment op-
tions is compromised. Instead, discussions are often
abridged with a focus on which patients require urgent
treatment, who can be delayed and how to best provide
oncological treatment with least risk to patients and
staff. Relevant professional bodies have issued guidance
and collaborative statements around management of
HNC patients during the pandemic (ENT-UK 2020),
which temporarily replace existing guidelines (National
Institute for Health and Clinical Excellence 2004). SLTs
may experience loss of professional identity within the
MDT, but more importantly delays to clinical input,
decision-making as well as losing the benefit of joint
working may have negative consequences for patients.
Patients may encounter mixed messages from the team
that can add confusion and anxiety to an already stress-
ful event of receiving a cancer diagnosis. This may esca-
late into negative consequences for building trust with
the team and could potentially influence patient en-
gagement and subsequent outcomes.
Cancer treatment regimes
The surgical and chemo/radiotherapy treatment
regimes for HNC have been adjusted in response
to the risks associated with coronavirus transmission
(Day et al. 2020). Accordingly, the British Association
of Head and Neck Oncologists (BAHNO) have is-
sued treatment decision guidance during the pandemic
(BAHNO 2020). They recommend avoidance of laryn-
gectomy procedures unless considered absolutely nec-
essary and to treat with radiotherapy instead. However,
voice and swallowing can be adversely affected in pa-
tients with advanced laryngo-pharyngeal cancer treated
with radiotherapy (Rosenthal et al. 2015). Further-
more, treating residual or recurrent disease with salvage
laryngectomy can lead to poorer voice and swallowing
outcome (Burnip et al. 2013). Where primary laryngec-
tomy is performed, tracheoesophageal puncture (TEP)
should be avoided to reduce the risk of early postop-
erative complications. Although a secondary TEP can
be performed later, SLTs will need to prepare and re-
habilitate patients using non-surgical voice-restoration
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methods. Access to appropriate communication aids
such as electrolarynx devices is therefore imperative.
BAHNO has also advised limiting operation times
wherever possible, for example, use of local flaps instead
of free flaps. Minimally invasive surgery is currently
not accessible (Day et al. 2020). This has implications
for functional outcome. For some, superior speech and
swallowing can be achieved with local flaps, where
structures are mobile and tethering is limited (Lam and
Samman 2013). However, large defects insufficiently re-
constructed can result in sumps and reduced proximity
of anatomical structures, affecting articulation accuracy
and pressure generation for efficient and safe swallow-
ing (Lam and Samman 2013). Furthermore, BAHNO
have advised restricting the use of chemoradiotherapy,
and treating solely with radiotherapy, wherever possible.
This alteration to traditional treatment regimes may
result in superior outcomes for swallowing as single
modality treatments tend to be less deleterious for func-
tional outcomes (Wilson et al. 2011). These adaptations
to treatment have implications for the pretreatment dis-
cussions SLTs have with patients and their expectations
for their subsequent function and rehabilitation.
It is also important to highlight that changes in
treatment regimes during the pandemic mean that
many patients will not receive the optimum treat-
ment plan they may have otherwise been offered.
The emotional and psychological response that in-
dividuals may have to this cannot be underesti-
mated and may be an important area for further
research.
Rehabilitation
Clinicians have had to be innovative in managing their
HNC outpatient caseloads. Whilst there is likely to be
much variation throughout the country, it is encour-
aging to note that large numbers SLT services have
proactively adapted to provide rehabilitation via tele-
phone (60.7%) and video-conferencing (43.6%) while
promoting self-management where possible (RCSLT
2020b). However, not all patients are suitable or indeed
receptive to telehealth, and the ramifications of delay-
ing rehabilitation will need to be carefully considered as
we move through the pandemic and decide on priori-
ties for restarting face-to-face services. RCSLT clinical
excellence networks (CENs) have played an important
part in disseminating and sharing experiences via social
media and through the CEN websites. Patient organiza-
tions such as the National Association of Laryngectomy
Clubs and the Swallows Charity amongst others have
also played an important supportive role for both pa-
tients and carers alike.
Voice services
Referral patterns
Referral patterns to voice and upper airway services will
depend upon the activity of existing referral sources
who may be seeing fewer patients, in conjunction
with anticipated increased demands from COVID-19
patients. New referral sources might include respiratory
medicine and intubation trauma services. Notably,
the newly proposed remote evidence-based triage sys-
tem described above (Paleri et al. 2020) could further
increase referrals for SLT-led EEL clinics. An ENT SLT-
led Two Week Wait HNC referral pathway for low risk
hoarse patients pilot study demonstrated an excellent
safety record for cancer screening and more efficient ac-
cess to voice services (Slade and McGlashan 2019). This
role extension requires clear protocols, parallel consul-
tant ENT input and Trust-level clinical governance
clearance. Delays to elective phonosurgery, including
injection laryngoplasty, may also demand intermediate
voice therapy and/or provision of amplification de-
vices (White 2019). Postponement of such treatments
could have huge psychosocial implications for patients,
particularly those who are socially isolating, as tele-
phone use is a common challenge for individuals with
dysphonia.
Clinical implications of COVID-19
Post-extubation injuries can include laryngeal oedema,
arytenoid dislocation, laryngeal ulceration and vocal
cord paralysis (Brodsky et al. 2018, McGrath et al.
2020). Notably, intubation can cause superficial mu-
cosal damage and stiffness, affecting vocal fold pliability
required for voicing (Hirano and Kakita 1985). Impli-
cations of such disorders can pose short- and long-term
challenges to communication, at a time when speaking
with loved ones and healthcare professionals is essen-
tial for well-being and enabling joint decision-making
to promote patient-centred care.
For those diagnosed with mild to moderate
COVID-19, 27% reported dysphonia, and was more
common in females and smokers (Lechien et al. 2020).
Time to recovery is as yet unreported.
Hyperfunctional voice/laryngeal disorders might
also present secondary to proliferate use of telecom-
munications for work and social interaction, speaking
through PPE and/or through increased levels of anxiety
(Besser et al. 2020). A ‘vicious cycle’ may arise between
anxieties and laryngeal function, particularly if laryn-
geal symptoms, pertinently breathlessness and cough,
are interpreted as manifestations of COVID-19 or
underlying disease progression. This might be partic-
ularly challenging for those with comorbid progressive
respiratory disease, for example, chronic obstructive
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pulmonary disease (COPD). Psychosocially, symp-
toms of chronic cough may receive negative attention
thus affecting well-being. SLTs might also see a rise
in psychogenic voice disorders. These could feasibly
arise in response to direct COVID-19 experiences;
or because of difficulties dealing with uncertainties
of COVID-19 which are likely affecting all aspects
of life.
Conversely, it is feasible that lockdown restrictions
will positively influence laryngeal function for existing
patients who developed dysphonia through high oc-
cupational vocal demands, owing to opportunities for
voice rest if unable to attend work. For such patients,
social and occupational restrictions may also provide
opportunity to engage more actively in rehabilitation
programmes.
Treatment implications
Face-to-face therapy delivery is the cornerstone of the
evidence for dysphonia treatment. Routine out-patient
treatment programmes are unlikely to be an option for
some time and as has been previously stated adaptations
towards telehealth practice are inevitable. Perceptual as-
sessment as a response to treatment trials is an essen-
tial tool yet is challenging in a virtual delivery mode.
The quality and type of microphone are key for de-
tailed capture of voice, and laryngeal function (Ward
et al. 2014). An acoustic speech processor may be useful
for measures of loudness, pitch and duration data (Wei-
dner and Lowman 2020); and controlling noise and
microphone position can reduce random error (Jan-
netts et al. 2019). Perceptual evaluation of upper body
tension, through video-consultation may also enhance
treatment. Distinct telehealth challenges may arise for
patients with moderate to severe dysphonia, notably
those with breathiness and asthenia.
Airway services
Patients with airway issues have been recommended to
shield themselves, similarly to other vulnerable groups
(Public Health England 2020). Complex airway pa-
tients are likely to be more susceptible to serious illness
and negative consequences of treatment if they are in-
fected with COVID-19. The clinical rationale for this is
threefold. First, patients who have undergone airway re-
construction procedures such as laryngotracheal recon-
struction (LTR) or cricotracheal resection (CTR) are
high risk and challenging to intubate (Crawley and Dal-
ton 2015). Second, prolonged ventilation of patients
with an altered airway is likely to lead to worse long-
term outcomes (e.g., further airway damage). Third, pa-
tients with complex airway disorders often experience
difficulties with cough strength and secretion clearance
(Tanner et al. 2019).
Assessment and monitoring
Rigorous triage is now necessary to identify the
highest risk patients for urgent procedures. Before
COVID-19, endoscopy and videofluoroscopy were key
adjuncts in the voice and swallowing management of
airways patients (Clunie et al. 2017). However, the loss
of instrumentation is an opportunity to showcase the
range of skills SLTs use to evaluate and treat swallow-
ing and voice difficulties with airways patients, as well
as continuing to work closely with the broader MDT to
form a clear, well-evidenced treatment plan for complex
airway patients. However, extended waiting lists and
subsequent increased patient anxiety because of treat-
ment delays is inevitable.
Attendance at highly specialist airway service clin-
ics frequently involve expensive, long-distance travel,
which can be burdensome for people requiring specialist
medical care. Telehealth is an opportunity to relieve this
burden for complex airway patients. Similar to the ex-
tended ENT SLT roles described above, there is also an
opportunity for developing SLT-led surveillance clinics
for complex airway patients. These allow ENT SLTs to
use their skills to monitor swallowing, voice and airway
problems remotely, and triage patients to ENT, nurs-
ing and psychology colleagues as required. This also has
benefits for patients as there is no unnecessary repetition
within their care pathway.
Long-term impact
Clinical consensus indicates that COVID-19 has the
potential to cause airway damage as a result of laryn-
geal manifestations of the disease (Tysome and Bhutta
2020); as well as expected long-term airway damage
due to prolonged intubation and need for tracheostomy
(Brodsky et al. 2018). As a result, airway services may
see an increase in referrals in the coming months as a
direct result of the virus itself. This is in addition to
the number of existing patients whose treatment has
been delayed in the initial response to the pandemic.
Airways SLTs will need to prepare for this potential in-
crease with forward workforce planning and upskilling
colleagues to assist with management of patients where
appropriate.
A summary of the main threats and opportunities
for ENT SLT clinical services is provided in table 1.
Workforce issues
COVID-19 presents members of the SLT profes-
sion with several workforce-related challenges including
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Table 1. Threats and opportunities for HNC, voice and airways SLT services
Main threats Main opportunities
All ENT/SLT • Increased workload and patient complexity
related to COVID-19 voice and airway
problems and delayed HNC diagnosis
• Reduced access to key instrumental procedures,
e.g., FEES, endoscopy, VF
• Inequitable care, affecting patients and services
without access to digital resources
• New modes of service delivery such as
telehealth/proxy consultation/multidisciplinary
and cross-service collaborations
• Increased skills and extended role: speech and
language therapy (SLT)-led assessment clinics
and increased scope of practice
• Harnessing SLT expertise in perceptual
assessment and non-instrumental assessments
Head and neck cancer
(HNC)
• Reduced opportunity for SLT input to
multidisciplinary team (MDT) meetings
• Challenges of providing face-to-face
consultations with high-risk groups in
particular, e.g., laryngectomy
• Lack of timely rehabilitation after oncology
treatment may lead to poorer long-term
outcomes
• Patient access to centralized specialist SLT
services via new modes of delivery
• Promotion of self-management where feasible
Voice and airways • Delayed or inaccurate diagnoses in absence of
laryngoscopy. Inappropriate treatment, and/or
escalating symptom severity
• Unknown prevalence of COVID-19-related
laryngeal disorders
• Increased profile of SLT for management and
rehabilitation of communication and upper
airway disorders
Note: FEES, Flexible Endoscopic Evaluation of Swallowing; VF, Videofluoroscopy.
redeployment of staff, capacity issues related to
COVID-19 staff sickness and increased demand with
new and emerging caseloads at a time of national emer-
gency. The recent Interim NHS People Plan (NHS Im-
provement 2019) recognizes that SLTs have broad rang-
ing skills, deliver high-quality care, limit unnecessary
care costs and are key in reducing reliance on hospi-
tals. Such workforce profiling and analysis suggests that
the SLT workforce is therefore well positioned to de-
velop and implement new strategies to deliver care dur-
ing and after the COVID-19 pandemic. Indeed, SLTs
have already rapidly adapted to the changing COVID-
19 healthcare landscape which has mandated a shift in
healthcare provision such as the shift towards telehealth
solutions described above.
Changes in workforce
As part of the national effort to manage COVID-
19, the Chief Allied Health Professionals in the UK,
Health and Care Professions Council (HCPC), Coun-
cil of Deans and Allied Health Professions Council
have asked practitioners to be flexible and adopt new
ways of working (NHS England 2020). To facilitate
practitioners in the transition of potential new roles the
governing bodies further specify provider organizations
must be supportive of new ways of working. Such
changes in working will be a departure from usual SLT
practice, but despite this, SLTs are urged to follow prin-
ciples of best practice, following HCPC guidance, and
to use professional judgement to assess risk. As well as
existing staff, there has been a call to former healthcare
practitioners to return to the frontline workforce with
expedited HCPC and RCSLT re-registration processes
in place. Students in advanced stages of their studies are
also being offered an opportunity to join a temporary
COVID-19 register (RCSLT 2020a).
Redeployment and meeting existing and emerging
needs
The RCSLT has fully supported the redeployment of
SLTs to support the health and social care system (RC-
SLT 2020a). However, services need to continue to sup-
port existing caseloads and new patients requiring input
for communication and swallowing impairments. Any
plans for the redeployment of SLTs must take account
of prioritized services, that is, those that cannot be sus-
pended due to the high risks involved if they did not
continue. SLTs can play a key role in the prevention
of hospital admissions and readmissions for vulnerable
groups in the community. Further, SLTs assist in expe-
diting inpatient discharge. Such contributions support
the government’s plan to shield the high risk and sup-
port wider risk groups (RCSLT 2020a).
The RCSLT has also highlighted the key skills and
expertise which SLTs have to meet some of the clin-
ical presentation needs of patients with COVID-19
(RCSLT 2020a). SLTs in many centres are being rede-
ployed, for example, to ICUs in ‘buddy’ roles to support
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nursing and medical staff managing acutely ill COVID-
19 patients. In addition to increased capacity, buddies
are being used to support pressures on service provision
due to increased COVID and non-COVID-related staff
sickness. The ability to undertake new roles should be
underpinned by access to appropriate training to pre-
pare individuals (RCSLT 2020a), and potentially the
opportunity to be upskilled to allow for continued pro-
fessional development.
It is also emerging that those recovering from
COVID-19 are requiring the specialist skills of SLTs
post-COVID-19 infection. In the ICU setting, if the
patient is intubated but awake, the SLT can support
communication including consent regarding treatment
decisions using alternative and augmentative communi-
cation options. When patients are extubated and mov-
ing to intermediate-level care, the SLT has an essential
role in the supporting communication, swallowing and
airway management (RCSLT 2020a). For patients who
are receiving end-of-life care, SLTs can play a key role
in advocacy and supporting quality-of-life-focused deci-
sions with regards to eating and drinking. Finally, SLTs
can support the consent process for recruitment to local
and national COVID-19 clinical research trials.
Health and well-being
At a time of heightened pressure on SLTs, consideration
needs to be given to COVID-19 and non-COVID-19-
related health burden. Given the rapid pace of change
in the healthcare landscape, usual consultation processes
with staff are not possible. The RCSLT has provided
a rapid response in producing guidance for the profes-
sion, including safety indications for PPE and aerosol-
generating procedures, applicable to ENT SLTs (Bolton
et al. 2020).
Given the uncertainty and anxieties that staff may
experience, NHS Employers (2020) have set out guid-
ance for leaders highlighting the importance of regular
and open communication. As well as physical health,
increased efforts have been made to address mental
health proactively with guidance for managers and sev-
eral services being offered by companies for free, for
example, Big Health, Headspace and Unmind (British
Psychological Society 2020).
Planning for the future of the workforce
The future remains uncertain, with the potential for
further COVID-19 case surges. However, healthcare
providers are already considering post-COVID-19 ser-
vice recovery and response plans. Healthcare organi-
zations will need to recognize new models of good
practice. As a part of this, workforce issues will be a
critical element for consideration. There may be shifts
from acute to community provision of services. Simi-
larly, the rapid transition from traditional, face-to-face
clinical service delivery to telehealth as described above
may well become embedded. However, some services
may not have adequate video-conferencing resources
and expertise, delaying access and increasing inequali-
ties in service provision. Likewise, the increased use of
information technology (IT) and virtual platforms for
meetings and sharing resources may facilitate ongoing
collaborative links across large geographical areas with
minimal travel or venue hire costs. This may mean SLTs
working remotely and making use of IT solutions which
have been rolled out to facilitate this.
There is now a staged return to SLT-led endoscopy
services (RCSLT 2020d). Consideration will be needed
for compliance with these guidelines and how this af-
fects current caseloads, regardless of COVID status.
This will be particularly challenging for training new
SLT endoscopists. Extended practice roles such as triage
systems and ENT SLT-led Two Week Wait clinics will
require further training, greater numbers of specialist
skilled staff and equipment resources. The main threats
and opportunities related to ENT/SLT workforce are
summarized in table 2.
Leadership and research
Leadership
NIHR CRN ENT SLT group members have exper-
tise in generating, implementing and disseminating
evidence-based practice while remaining patient facing.
They have extensive clinical research networks to en-
sure that their contributions to strategic direction on
issues affecting ENT SLT delivery of care. The group
has a shared focus and provides a forum for collec-
tive learning, innovation and research prioritization. It
works across geographical and service boundaries and
is driving high-quality research that is clinically rele-
vant and implementable across services. As described
above, clinical issues and service delivery have altered
at a fast pace, with little time to evaluate the evidence
for such changes. This period of instability and change
in priority-focus requires a rethink of the ENT SLT col-
lective research strategy.
National research priorities
The ENT SLT research profile across the UK has sev-
eral multidisciplinary, multi- and single-centre stud-
ies open to recruitment and follow-up (e.g., PATHOS
CRUK/13/025 CPMS 18645; DARS CRUK/14/014
CPMS 19934; PITSTOP CPMS 39932) supported
by the NIHR Portfolio. In addition, there are many
studies led by ENT SLTs, funded by the NIHR
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Table 2. Main threats and opportunities for the speech and language therapy (SLT) workforce in ear, nose and throat
(ENT)/laryngology specialty areas
Main threats Main opportunities
• Hands on training in endoscopic evaluation of the larynx (EEL), FEES and SVR
• Redeployment and impact on existing services
• Psychological impact on the SLT workforce
• Service innovation and models of care
• Extended ENT/SLT practice roles
• Implementation of telehealth services
Note: FEES, Flexible Endoscopic Evaluation of Swallowing; SVR, Surgical Voice Restoration.
Integrated Clinical Academic Programme as well as
charitable funding. Currently, the NIHR, Medical and
Healthcare products Regulatory Agency (MHRA), and
European Medicines Agency (EMA) have prioritized
nationally sponsored COVID-19 studies and delivery
of urgent public health research, vaccines and medicines
(NIHR 2020, MHRA 2020, EMA 2020). The NHS
Health Research Agency (HRA) has enabled a fast-
track ethical-approval process to expediate study set-up
and provided advice on information and consent pro-
cedures for emergency research projects (NHS HRA
2020). NIHR clinical academic staff are advised to re-
turn to frontline care as directed by their employer. This
means pausing ‘live’ studies and halting those in prepa-
ration. However, some host organizations have agreed
that non-COVID studies may continue, particularly
where stopping a study may impact on patient care.
ENT SLT research
The pandemic has slowed the progress of research into
non-COVID-19 topics, created major disruption for
ENT SLT-related studies and arrested NIHR clinical
fellowships. Common methodologies and methods
used in ENT SLT research have been challenged and
will continue to be in the post-COVID era. For ex-
ample, studies conducting instrumental tests are now
severely restricted and their reintroduction into clin-
ical, let alone research, practice is unclear, but likely
to be slow. Furthermore, SLT research is frequently
‘patient-facing’ and multidisciplinary. Commonly used
methods such as focus groups and co-design, with
face-to-face contact for non-essential activities, and in
particular group gatherings will be restricted for some
time. Again, these activities may continue via telephone
or video-conferencing, while recognizing potential ex-
clusion of those unable or unwilling to access IT. Access
to vulnerable patient groups, for example, older adults,
people with a laryngectomy or tracheostomy will be fur-
ther limited for an extended, undefined period of time.
Conducting patient and public involvement events to
establish research priorities and collaboration will be
challenging. Furthermore, opportunities to disseminate
research have reduced, with cancellation of interna-
tional and national face-to-face meetings although
some have transferred to virtual conference platforms.
Funding
Many UK research councils are redirecting or repurpos-
ing funding to enable new treatments, diagnostics and
vaccines to contribute to the understanding of, and re-
sponse to, the COVID-19 pandemic and its impacts
(UK Research and Innovation 2020). The NIHR have
now opened a funding call for research into COVID-
19 pandemic beyond the acute phase (NIHR 2020b).
Charitable research funders have experienced significant
downturn in their income necessitating an immediate
cut in research spending. For example, Cancer Research
UK (CRUK) predict this will set back the UK cancer re-
search programme, potentially for many years, and are
postponing funding decisions for the majority of 2020.
Research opportunities
RCSLT Clinical Excellence Networks and the NIHR
CRN ENT SLT Research Group have been essential to
information dissemination, best practice and problem-
solving. Agreement on prospective data collection to
evaluate altered service models is an imperative. Lim-
ited learning will occur if this work is conducted uni-
professionally, in silos with small single-centre data col-
lection. National databases have been set up, including
the RCSLT COVID-19 and Head and Neck Oncol-
ogy CEN Laryngectomy data set, ENT-UK National
COVID-19 Tracheostomy Service Evaluation to inves-
tigate voice and swallowing outcomes and changes to
service provision.
Now more than ever, there is a need to upskill to
generate and evaluate the best evidence to respond to
this changed landscape. The NIHR recognizes the im-
portance of maintaining a research pipeline and their
funding and training schemes will remain open, with
some changes to application deadlines The NIHR CRN
ENT SLT group have met to discuss research priorities
for clinical considerations and service delivery. Exam-
ples of these priorities include:
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Table 3. Main threats and opportunities for speech and language therapy (SLT) clinical research in ear, nose and throat
(ENT)/laryngology
Main threats Main opportunities
• Reduction in funding calls and high competition
• Current research affected by access to participants and
ability to conduct face-to-face and instrumental assessments
• Greater collaboration across ENT SLT group
• Changes in service delivery warranting further investigation
• Generation of national databases
• New set of research priorities
• Understanding post-extubation laryngeal trauma,
its impact, trajectory for recovery and manage-
ment of associated voice and swallowing prob-
lems.
• Identifying risk factors for dysphagia following
tracheostomy placement and effective dysphagia
rehabilitation.
• Understanding the respiratory–swallow cycle,
cough and laryngeal function in patients with
acute and chronic respiratory disease.
• Reliability and validity of non-invasive voice and
swallowing screening and assessment tools, in-
cluding those that can be conducted remotely.
• Collection of standardized outcome measures, us-
ing digital technologies where possible.
• Impact of altered HNC treatment schedules on
functional outcome.
Service delivery and models of care need evaluation
and further development as to how we can best support
patients, the workforce and the NHS as a whole. Exam-
ples of priorities include:
• Provision of remote highly specialist care for our
most vulnerable patients.
• Extent of AGP for routine ENT SLT procedures
and how they are best managed.
• Models of telehealth for ENT SLT services.
• Implementation of ENT SLT-led clinics and
triaging.
• The main threats and opportunities to ENT/SLT
research are summarized in table 3.
Discussion
The aim of this paper was to provide an expert discus-
sion on the threats and opportunities from the COVID-
19 pandemic for SLTs in ENT/laryngology practice.
The NIHR CRN ENT SLT Research Group repre-
sents a collaboration of experienced clinical researchers
in ENT/laryngology with a broad geographical repre-
sentation across England.
It is clear that the COVID-19 pandemic has had
and will continue to have a significant impact on all as-
pects of SLT practice and research in ENT/laryngology
(HNC, voice and airway disorders). The implica-
tions of the current situation with respect to the
ENT/laryngology clinical area are significant, but with
recognition of there is considerable overlap with SLT
services in respiratory care, critical care and dysphagia
care generally. It is also recognized that there are several
major issues that require evaluation for the whole of the
NHS workforce (e.g., PPE provision and mental health
and well-being) (Sayburn 2020, Unadkat and Farquhar
2020). Whilst these issues are highly relevant to many
SLTs, the issues are not profession specific and conse-
quently mentioned only briefly here.
It is evident that the immediate impact of the pan-
demic has resulted in major disruption to all aspects of
clinical delivery, workforce and research. It remains un-
clear as to when any of these areas will resume oper-
ations and if the post-COVID era will have changed
clinical practice, professional remits and research pri-
orities forever. Clearly a significant opportunity exists
in the post-COVID era to re-evaluate current practice,
embrace and evaluate new ways of working, requiring
strategic planning, coordination, collaboration, and dis-
semination across the UK.
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